E0 ConsensusModerate confidencePEM unclearGuidelinePeer-reviewedMachine draft
[Medical clinical diagnostics for indoor mould exposure - Update 2023 (AWMF Register No. 161/001)].
Hurraß, Julia, Heinzow, Birger, Walser-Reichenbach, Sandra et al. · Pneumologie (Stuttgart, Germany) · 2024 · DOI
Quick Summary
This guideline reviews what we know about indoor mold exposure and health problems. While mold in homes can be a health concern, the evidence shows it definitely causes respiratory allergies and asthma problems, but there is currently insufficient evidence to link mold exposure to chronic fatigue syndrome (CFS) or many other conditions.
Why It Matters
For ME/CFS patients, this guideline is important because it provides authoritative evidence synthesis on whether indoor mold could be a contributing factor. The explicit classification of CFS as having 'inadequate or insufficient evidence' for mold causation may help patients and clinicians avoid misdirected investigations into environmental exposures while still acknowledging mold as a legitimate health hazard for respiratory conditions that can co-occur with or complicate ME/CFS.
Observed Findings
- Strong evidence exists for mold-associated allergic respiratory diseases, asthma, bronchitis, hypersensitivity pneumonitis, and aspergillosis infections
- Mold sensitization prevalence in the general European population is comparatively low at 3–22.5%
- Inadequate or insufficient evidence exists for associations between mold and chronic fatigue syndrome, autoimmune diseases, mycotoxicosis, multiple chemical sensitivity, neuropsychological effects, and multiple sclerosis
- Odor effects and mood disorders can occur with indoor mold exposure but are not classified as acute health hazards
- Most indoor mold species pose low infection risk for healthy persons; immunocompromised patients, those with severe influenza/COVID-19, and cystic fibrosis patients require particular protection
Inferred Conclusions
- Indoor mold growth represents a potential health risk primarily for allergic and respiratory diseases, with low risk for healthy populations
- No causal relationship between mold/moisture damage and CFS or numerous other conditions can be established with current evidence and diagnostic methods
- Rational clinical diagnostics should focus on detailed history, physical examination, and conventional allergy testing rather than unvalidated mycotoxin assays
- Precautionary prevention of significant indoor mold infestation is appropriate despite unclear causation for many reported symptoms
What This Study Does Not Prove
This guideline does not prove that mold exposure never affects CFS patients, only that current scientific evidence is insufficient to establish a causal relationship. It does not address whether mold might indirectly worsen ME/CFS through respiratory infections or immune activation. The absence of evidence for causation reflects inadequate diagnostic methods and the ubiquitous presence of fungi, not necessarily absence of risk.
Metadata
- DOI
- 10.1055/a-2194-6914
- PMID
- 39424320
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →